$9.33
-0.48 (-4.89%)
Simcere Pharmaceutical Group (NYSE:SCR)
CAPS Rating:
The Company is a manufacturer and supplier of branded generic pharmaceuticals in the fast growing China market.
The Company is a manufacturer and supplier of branded generic pharmaceuticals in the fast growing China market.